229 related articles for article (PubMed ID: 25876489)
1. [Analysis on HIV suppression effect after initiating antiretroviral treatment and related factors among AIDS patients in Henan province during 2008 and 2013].
Yang W; Fan P; Liang Y; Li J; Ma Y; Li N; Sun D; Zhu Q; Wang Z
Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Jan; 49(1):13-20. PubMed ID: 25876489
[TBL] [Abstract][Full Text] [Related]
2. [Survival analysis of AIDS patients of 15 years or above years old after initiation antiretroviral treatment in Henan province during 2005 to 2014].
Yang W; Fan P; Liang Y; Nie Y; Li N; Sun D; Zhu Q; Wang Z
Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Dec; 49(12):1061-6. PubMed ID: 26887300
[TBL] [Abstract][Full Text] [Related]
3. Clinical, Immunological and Virological Responses of Zidovudine-Lamivudine-Nevirapine
Sorsa A
Open Med Inform J; 2018; 12():11-18. PubMed ID: 29875890
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
5. Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults.
Siegfried NL; Van Deventer PJ; Mahomed FA; Rutherford GW
Cochrane Database Syst Rev; 2006 Apr; 2006(2):CD004535. PubMed ID: 16625606
[TBL] [Abstract][Full Text] [Related]
6. [Safety study of 52-week highly active antiretroviral therapy in 198 HIV/AIDS Chinese patients].
Li WJ; Dai Y; Han Y; Qiu ZF; Xie J; Zuo LY; Li YL; Li TS
Zhonghua Yi Xue Za Zhi; 2011 May; 91(19):1318-22. PubMed ID: 21756757
[TBL] [Abstract][Full Text] [Related]
7. Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database.
Zhou J; Paton NI; Ditangco R; Chen YM; Kamarulzaman A; Kumarasamy N; Lee CK; Li PC; Merati TP; Phanuphak P; Pujari S; Vibhagool A; Zhang F; Chuah J; Frost KR; Cooper DA; Law MG
HIV Med; 2007 Jan; 8(1):8-16. PubMed ID: 17305926
[TBL] [Abstract][Full Text] [Related]
8. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of human immunodeficiency virus type 1-infected Chinese patients treated with highly active antiretroviral therapy for two years.
Zhou HY; Zheng YH; Zhang CY; Chen J; He Y; Ding PP; Li H
Viral Immunol; 2007; 20(1):180-7. PubMed ID: 17425432
[TBL] [Abstract][Full Text] [Related]
10. A pilot study to assess the immunologic and virologic efficacy of generic nevirapine, zidovudine and lamivudine in the treatment of HIV-1 infected women with pre-exposure to single dose nevirapine or short course zidovudine and their spouses in Chitungwiza, Zimbabwe.
Zijenah LS; Kadzirange G; Rusakaniko S; Kufa T; Gonah N; Tobaiwa O; Gwanzura C; Matsikire E; Katzenstein DA
Cent Afr J Med; 2006; 52(1-2):1-8. PubMed ID: 17892232
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of anti-HIV treatment and drug-resistance mutations in some parts of China].
Han XX; Zhang M; Cui WG; Liu BG; Wang Yn; Zhang ZN; Liu J; Geng WQ; Diao YY; Dai D; Jiang YJ; Shang H
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):760-4. PubMed ID: 15949383
[TBL] [Abstract][Full Text] [Related]
12. Impact of peer support on virologic failure in HIV-infected patients on antiretroviral therapy - a cluster randomized controlled trial in Vietnam.
Cuong DD; Sönnerborg A; Van Tam V; El-Khatib Z; Santacatterina M; Marrone G; Chuc NT; Diwan V; Thorson A; Le NK; An PN; Larsson M
BMC Infect Dis; 2016 Dec; 16(1):759. PubMed ID: 27986077
[TBL] [Abstract][Full Text] [Related]
13. Is zidovudine first-line therapy virologically comparable to tenofovir in resource-limited settings?
Labhardt ND; Bader J; Lejone TI; Ringera I; Puga D; Glass TR; Klimkait T
Trop Med Int Health; 2015 Jul; 20(7):914-8. PubMed ID: 25782332
[TBL] [Abstract][Full Text] [Related]
14. Effect of different antiretroviral therapy on muscle mass, bone mineral density, and trabecular bone score in Chinese HIV-infected males.
Zhang Z; Lin Q; Xu Y; Guan W; Song X; Li Y; Zhang Y; Li T; Yu W
Arch Osteoporos; 2023 Apr; 18(1):48. PubMed ID: 37041320
[TBL] [Abstract][Full Text] [Related]
15. Three generic nevirapine-based antiretroviral treatments in Chinese HIV/AIDS patients: multicentric observation cohort.
Li T; Dai Y; Kuang J; Jiang J; Han Y; Qiu Z; Xie J; Zuo L; Li Y
PLoS One; 2008; 3(12):e3918. PubMed ID: 19081791
[TBL] [Abstract][Full Text] [Related]
16. Comparing the effectiveness of efavirenz and nevirapine for first-line antiretroviral therapy in a South African multicentre cohort.
Bock P; Fatti G; Grimwood A
Int Health; 2013 Jun; 5(2):132-8. PubMed ID: 24030113
[TBL] [Abstract][Full Text] [Related]
17. An antiretroviral regimen containing 6 months of stavudine followed by long-term zidovudine for first-line HIV therapy is optimal in resource-limited settings: a prospective, multicenter study in China.
Li T; Guo F; Li Y; Zhang C; Han Y; Lye W; He Y; Lu H; Xie J; Huang A; Li Y; Tang X; Wang H; Zhang T; Gao G; Lei J; Zhang X; Wu X; Sun Y; Bai J; Luo L; Wang H
Chin Med J (Engl); 2014; 127(1):59-65. PubMed ID: 24384425
[TBL] [Abstract][Full Text] [Related]
18. Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon.
Laurent C; Bourgeois A; Mpoudi-Ngolé E; Ciaffi L; Kouanfack C; Mougnutou R; Nkoué N; Calmy A; Koulla-Shiro S; Delaporte E
AIDS Res Hum Retroviruses; 2008 Mar; 24(3):393-9. PubMed ID: 18327976
[TBL] [Abstract][Full Text] [Related]
19. Long-term viral suppression and immune recovery during first-line antiretroviral therapy: a study of an HIV-infected adult cohort in Hanoi, Vietnam.
Tanuma J; Matsumoto S; Haneuse S; Cuong DD; Vu TV; Thuy PTT; Dung NT; Dung NTH; Trung NV; Kinh NV; Oka S
J Int AIDS Soc; 2017 Dec; 20(4):. PubMed ID: 29211347
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and risk factors for developing K65R mutations among HIV-1 infected patients who fail an initial regimen of fixed-dose combination of stavudine, lamivudine, and nevirapine.
Sungkanuparph S; Manosuthi W; Kiertiburanakul S; Saekang N; Pairoj W; Chantratita W
J Clin Virol; 2008 Apr; 41(4):310-3. PubMed ID: 18316243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
